1. Food and Drug Administration. Pediatric studies – annual status summary, no date. (
www.fda.gov/downloads/scienceresearch/specialtopics/pediatrictherapeuticsresearch/ucm308465.pdf
.)
2. Food and Drug Administration. Consumer updates: giving drugs to children, 2015. (
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm164427.htm
.)
3. Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 2006;5:703–18.
4. Food and Drug Administration. Formulations: pediatric formulations in accordance with sections 505A(f)(6)(D) and 505B(f)(6)(F) of the Federal Food, Drug, and Cosmetic Act, as amended by the FDA Amendments Act (FDAAA), 2014. (
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/ucm049872.htm
.)
5. National Library of Medicine. NITROPRESS®: Sodium Nitroprusside Injection, solution, concentrate, 2014. (
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bf27f0a9-e64b-492a-b08f-2448bf097988
.)